Decisive point for gensight in the short termSolid'action which is about to exceed probably € 10 in the short term if we go above € 9.35 at 11:45 am.
−0.5425EUR
−26.20 MEUR
3.00 MEUR
54.00 M
About GENSIGHT BIOLOGICS SA EUR0.025
Sector
CEO
Laurence Rodriguez
Headquarters
Paris
Website
Founded
2012
ISIN
FR0013183985
FIGI
BBG00JHW7HX8
GenSight Biologics SA is a clinical-stage gene therapy company. It is engaged in research and development of novel therapies for mitochondrial and neurodegenerative. The firm also provides ophthalmology services which develops products to restore eyesight to patients suffering from retinal diseases. The company was founded by Bernard Jacques Alex Gilly, Botond Roska, Jean Bennett, Connie Cepko, Luk H. Vandenberghe, Serge Picaud and Jose-Alain Sahel in 2012 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0RIM is 0.4000 EUR — it has increased by 0.51% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange GENSIGHT BIOLOGICS SA EUR0.025 stocks are traded under the ticker 0RIM.
GENSIGHT BIOLOGICS SA EUR0.025 is going to release the next earnings report on Sep 23, 2024. Keep track of upcoming events with our Earnings Calendar.
0RIM stock is 0.51% volatile and has beta coefficient of 0.23. Check out the list of the most volatile stocks — is GENSIGHT BIOLOGICS SA EUR0.025 there?
One year price forecast for GENSIGHT BIOLOGICS SA EUR0.025 has a max estimate of 0.4000 EUR and a min estimate of 0.4000 EUR.
Yes, you can track GENSIGHT BIOLOGICS SA EUR0.025 financials in yearly and quarterly reports right on TradingView.
0RIM stock has fallen by 0.74% compared to the previous week, the month change is a 15.25% fall, over the last year GENSIGHT BIOLOGICS SA EUR0.025 has showed a 83.19% decrease.
0RIM net income for the last quarter is −14.24 M EUR, while the quarter before that showed −11.96 M EUR of net income which accounts for −19.03% change. Track more GENSIGHT BIOLOGICS SA EUR0.025 financial stats to get the full picture.
Today GENSIGHT BIOLOGICS SA EUR0.025 has the market capitalization of 32.96 M, it has increased by 1.12% over the last week.
No, 0RIM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0RIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENSIGHT BIOLOGICS SA EUR0.025 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENSIGHT BIOLOGICS SA EUR0.025 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENSIGHT BIOLOGICS SA EUR0.025 stock shows the sell signal. See more of GENSIGHT BIOLOGICS SA EUR0.025 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GENSIGHT BIOLOGICS SA EUR0.025 future price: according to them, 0RIM price has a max estimate of 0.40 EUR and a min estimate of 0.40 EUR. Read a more detailed GENSIGHT BIOLOGICS SA EUR0.025 forecast: see what analysts think of GENSIGHT BIOLOGICS SA EUR0.025 and suggest that you do with its stocks.